New Dystonia Drug Candidates Discovered

Jeffrey Conn, founding director of Warren Center for Neuroscience Drug Discovery, named 2021 fellow of American Society for Pharmacology and Experimental Therapeutics

Vanderbilt-developed obesity treatments will be advanced through collaboration with Soleno Therapeutics